STRAUMANN HLDG NA SF 0,01
STRAUMANN HLDG NA SF 0,01/ CH1175448666 /
QS51
|
- -
|
Chg.
-
|
Volume |
Bid- |
Demandez à- |
Capitalisation boursière |
Dividende Y. |
Rapport P/E |
|
-EUR
|
-
|
-
Chiffrre d'affaires: - |
-Bid taille: - |
-Ask la taille: - |
18.89 Mrd.EUR |
- |
- |
Description de l'entreprise
Headquartered in Basel, Switzerland, Straumann (SIX: STMN) is a global leader in implant, restorative and regenerative dentistry. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and biomaterials for use in tooth replacement and restoration solutions or to prevent tooth loss.
Conseil d'administration & Conseil de surveillance
| PDG |
| Guillaume Daniellot |
| Conseil d'administration |
| Yang Xu, Jason Forbes , Patrick Loh , Alastair Robertson, Sébastien Roche, Aurelio Sahagun, Matthias Schupp, Sara Dalmasso, Thomas Friese, Holger Haderer, Florian Kirsch |
| Conseil de surveillance |
| Petra Rumpf, Dr. Thomas Straumann, Marco Gadola, Regula Wallimann, Xiaoqun Clever-Steg, Stefan Meister, Olivier Filliol |
Données de l'entreprise
| Nom: |
Straumann Holding AG |
| Adresse: |
Peter Merian-Weg 12,CH-4052 Basel |
| Téléphone: |
+41-61-965-1111 |
| Fax: |
+41-61-965-1101 |
| Courriel: |
info@straumann.com
|
| Internet: |
www.straumann.com |
| Industrie: |
Healthcare |
| Secteur: |
Medical Products |
| Sous-secteur: |
Advanced Medical Devices |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
57.90% |
| IPO date: |
01/01/1998 |
Calendrier de l'entreprise
|
CW 8 | 19/02/2025
4th Quarter/Annual Report
|
